2004 FEB 26 - (NewsRx.com & NewsRx.net) -- AcroMetrix announced that it has completed the acquisition of the ViroSure product line previously manufactured by Nabi Biopharmaceutical's antibody business and other assets related to its diagnostics business.
As a result of the acquisition, AcroMetrix will obtain U.S. Food and Drug Administration (FDA) approved ViroSure Multi-Marker quality control products for use in blood testing laboratories.
The ViroSure products expand and enhance AcroMetrix's quality control product offerings to the blood screening and clinical diagnostic markets. ViroSure is one of only two quality control products for Hepatitis and HIV …
No comments:
Post a Comment